Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 323-332

  Wilson, G D ^a   Paschoud, N ^b   Pavy, J J ^c   Weber, K ^b   Weber, P ^b   Dubray, B ^d   Coucke, P A ^e  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b Laboratory of Clinique de La Source   (Switzerland)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d INSTITUT CURIE   (France)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Conventional radiotherapy; Flow cytometry; Multicentre; Proliferation; Reproducibility

Indexed keywords

BROXURIDINE; MONOCLONAL ANTIBODY; TRYPSIN;

ARTICLE; CELL CYCLE S PHASE; CELL DIVISION; CONTROLLED STUDY; DATA ANALYSIS; DEVICE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LABELING INDEX; LABORATORY DIAGNOSIS; PLOIDY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; TUMOR BIOPSY; TUMOR CELL;

EID: 0032919963     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690052     Document Type: Article

References (27)

1. Begg AC (1995) The clinical status of Tpot as a predictor? Or why no tempest in the Tpot! Int J Radiat Oncol Biol Phys 32: 1539-1541
2. Begg AC, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Le Fir R, Van den Bogaert W, Caspers R, van Glabbeke M and Horiot J-C (1990) The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumours: an interim report. Int J Radiat Oncol Biol Phys 19: 1449-1453
3. Begg AC, Moonen L, Hofland I, Dessing M and Bartelink H (1988) Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine; intratumour sampling variations. Radiother Oncol 11: 337-347
4. Begg AC, McNally NJ, Shrieve DC and Karcher HA (1985) A method to measure the DNA synthesis and the potential doubling time from a single sample Cytometry 6: 620-626
5. Bennett MH, Wilson GD, Dische S, Saunders MI, Martindale CA and Robinson BM (1992) Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 65: 870-878
6. Bland MJ and Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i: 307-310
7. Bourhis J, Wilson G, Wibault P, Bosq J, Chauvaudra N, Janot F, Luboinski B, Eschwege F and Malaise EP (1993) In vivo measurement of potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys 26: 793-799
8. Corvo R, Giaretti W, Sanguinsti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A and Vitale V (1993) Potential doubling time in head and neck tumours treated by primary radiotherapy - preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol Biol Phys 27: 1165-1172
9. Dische S, Saunders M, Barrett A, Harvey A, Gibson D and Parmar M (1997) A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44: 123-136
10. Fowler JF (1990) How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. Radiother Oncol 18: 165-181
11. Fowler JF and Lindstrom M (1992) Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23: 457-467
12. Haustermans K, Hofland I, Pottie G, Ramaekers M and Begg AC (1995) Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study. Cytometry 19: 154-163
13. Horiot JC, Bontemps P, van den Bogaert W, Le Fur R, van den Weijngaert D, Bolla M, Bernier J, Lusinchi A, Stuschke M, Lopex-Torrecilla J, Begg AC, Pierart M and Collette L (1997) Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44: 111-121
14. Peters LJ, Ang KK and Thames HJ (1988) Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol 27: 185-194
15. Shackney SE and Shankey TV (1995) Genetic and phenotypic heterogeneity of human malignancies: Finding order in chaos. Cytometry 21: 2-5
16. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KB, Duque RE, Hedley DW, Mayall BH, Wheeless L and Cox C (1993) Guidelines for implementation of clinical DNA cytometry. Cytometry 14: 472-477
17. Steel GG (1977) Growth Kinetics of Tumours. Clarendon Press: Oxford
18. Terry NHA and Peters LJ (1995) The predictive value of tumour cell kinetic parameters in radiotherapy: Considerations regarding data production and analysis. J Clin Oncol 13: 1833-1836
19. Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Rawlings GA, Banerjee M, Pintillie M and Wilson GD (1995) Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: preliminary results. Int J Radiat Oncol Biol Phys 32: 1319-1329
20. Wheeless LL, Coon JS, Cox C, Deitch AD, deVere White RW and Fradet V (1991) Precision of DNA flow cytometry in inter-institutional analyses. Cytometry 12: 405-412
21. Wheeless LL, Coon JS, Cox C, Deitch AD, deVere White RW and Koss LG (1989) Measurement variability in DNA flow cytometry of replicate samples. Cytometry 10: 731-738
22. White RA and Terry NHA (1992) A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine. Cytometry 13: 490-495
23. White RA, Terry NHA, Meistrich ML and Calkins, DP (1990) An improved method for computing the potential doubling time using monoclonal antibodies to bromodeoxyuridine. Cytometry 11: 314-317
24. Wilson GD, McNally NJ, Dische S, Saunders MI, Des Rochers C, Lewis AA and Bennett MH (1988) Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 58: 423-431
25. Wilson MS, West CM, Wilson GD, Roberts SA, James RD and Schofield PF (1993a) An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer 67: 754-759
26. pot) in colorectal cancer. Br J Cancer 68: 501-506
27. Withers HR, Taylor JMG and Maciejewski B (1988) The haxard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 27: 131-146